Preventive Cardio-Oncology: Cardiovascular Disease Prevention in Cancer Patients and Survivors

Keyphrases

• In Cancer 100%
• Cancer Patients 100%
• Cardioprotection 100%
• Cardiovascular Prevention 100%
• Cancer Survivors 100%
• Cardiovascular Toxicity 100%
• Cardio-oncology 100%
• Atrial Fibrillation 66%
• Cardiovascular Disease 66%
• Most Common Form 66%
• Patient Care 33%
• Ischemia 33%
• Chemotherapy 33%
• Cardiomyopathy 33%
• Gene Expression Profile 33%
• Lifesaving 33%
• Secondary Cancer 33%
• Leading Causes of Death 33%
• Cardiovascular Risk 33%
• Preventive Measures 33%
• Genome-wide Expression 33%
• Pharmacologic 33%
• Screening Method 33%
• Risk Reduction 33%
• Pharmacological Therapy 33%
• Patient Management 33%
• Risk Stratification 33%
• Hypertension 33%
• Monitoring Method 33%
• Anticancer Drugs 33%
• Risk Prediction 33%
• Randomized Clinical Trial 33%
• Multimodality 33%
• Lifestyle Modification 33%
• Multidisciplinary Team 33%
• Cancer Recurrence 33%
• Common Risk Factors 33%
• Risk Factor Management 33%
• Personalized Medicine 33%
• Transcriptomics 33%
• Cardiotoxicity 33%
• Cancer Drug Therapy 33%
• Cancer Radiation Therapy 33%
• Chemotherapy Administration 33%
• Surveillance Methods 33%
• Management Methods 33%
• Preventive Tools 33%
• Lifestyle Therapy 33%
• Artificial Intelligence Techniques 33%
• Prediction Strategy 33%
• Risk-based Surveillance 33%
• Multidisciplinary Team Management 33%
• Precision Intervention 33%
• Sodium-glucose Cotransporter Inhibitors 33%
• Clonal Hematopoiesis of Indeterminate Potential 33%
• Precision Monitoring 33%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Cardiovascular Disease Prevention 100%
• Cardio-Oncology 100%
• Cardiovascular Disease 75%
• Cardiovascular Toxicity 75%
• Patient Care 50%
• Gene Expression 50%
• Atrial Fibrillation 50%
• Heart Protection 50%
• Ischemia 25%
• Metastatic Carcinoma 25%
• Radiation Therapy 25%
• Myocardial Disease 25%
• Risk Reduction 25%
• Drug Therapy 25%
• Risk Stratification 25%
• Anticarcinogen 25%
• Cancer Recurrence 25%
• Hematopoiesis 25%
• Lifestyle Modification 25%
• Transcriptomics 25%
• Personalized Medicine 25%
• Cardiotoxicity 25%
• Sodium Glucose Cotransporter Inhibitor 25%
• Artificial Intelligence 25%
• Randomized Clinical Trials 25%